Concepedia

Shanta Bantia

SB

Statistics

Publications

39

Citations

2.8K

H-Index

26

Active since

1996

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

University of Alabama at Birmingham

The University of Texas MD Anderson Cancer Center

University of Oklahoma

Australian National University

Shanta Bantia is an author at BioCryst Pharmaceuticals (United States) specializing in pharmacology, antiviral pharmacology, and medicine.

ORCID

Publications per year

1996–2022

39

Publications

39

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Travis K. Warren, Jay Wells, Rekha G. Panchal et al. · Nature · 2014 · 607 citations · Full text

, , +11

BCX-1812 (RWJ-270201):  Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Y.S. Babu, Pooran Chand, Shanta Bantia et al. · Journal of Medicinal Chemistry · 2000 · 378 citations · Full text

, , +6

Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity

Pooran Chand, Pravin L. Kotian, Ali Dehghani et al. · Journal of Medicinal Chemistry · 2001 · 175 citations · Full text

, , +15

Anti-influenza virus activity of peramivir in mice with single intramuscular injection

Shanta Bantia, Carrie Arnold, Cynthia Parker et al. · Antiviral Research · 2005 · 149 citations

, , +13

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

Shanta Bantia, Cynthia Parker, Sandya L. Ananth et al. · Antimicrobial Agents and Chemotherapy · 2001 · 148 citations · Full text

, , +15

1–5 of 39